Spironolactone in pulmonary arterial hypertension: results of a cross-over study

The renin–angiotensin–aldosterone system is implicated in the pathophysiology of pulmonary arterial hypertension. We undertook this study to determine the effects of spironolactone, a mineralocorticoid receptor blocker, on collagen metabolism in pulmonary arterial hypertension patients. After obtain...

Descripción completa

Detalles Bibliográficos
Autores principales: Safdar, Zeenat, Frost, Adaani, Basant, Arya, Deswal, Anita, O’Brian Smith, E., Entman, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219009/
https://www.ncbi.nlm.nih.gov/pubmed/32426108
http://dx.doi.org/10.1177/2045894019898030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219009/
https://www.ncbi.nlm.nih.gov/pubmed/32426108
http://dx.doi.org/10.1177/2045894019898030

Ejemplares similares